TABLE OF CONTENTS
1 INTRODUCTION 31
1.1 OBJECTIVES OF THE STUDY 31
1.2 MARKET DEFINITION 31
1.3 OVERVIEW OF THE ASIA-PACIFIC HEARING AID MARKET 31
1.4 LIMITATIONS 33
1.5 MARKETS COVERED 34
2 MARKET SEGMENTATION 37
2.1 MARKETS COVERED 37
2.2 GEOGRAPHICAL SCOPE 38
2.3 YEARS CONSIDERED FOR THE STUDY 38
2.4 CURRENCY AND PRICING 38
2.5 DBMR TRIPOD DATA VALIDATION MODEL 39
2.6 PRODUCT TYPE TIMELINE CURVE 42
2.7 MULTIVARIATE MODELING 43
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 44
2.9 DBMR MARKET POSITION GRID 45
2.10 MARKET APPLICATION COVERAGE GRID 46
2.11 VENDOR SHARE ANALYSIS 47
2.12 SECONDARY SOURCES 48
2.13 ASSUMPTIONS 48
3 EXECUTIVE SUMMARY 49
4 PREMIUM INSIGHTS 51
4.1 PORTERS FIVE FORCES 52
4.2 PESTEL ANALYSIS 53
4.3 TECHNOLOGICAL INNOVATION 56
4.4 KEY STRATEGIC INITIATIVE 59
4.5 REVIEW FROM END-USER 60
4.5.1 BY PRODUCT/BRAND 60
4.5.2 BY COMPANY 61
4.6 DIGITAL HEALTH REGULATION IN ASIA-PACIFIC 63
4.6.1 AUSTRALIA 63
4.6.1.1 REGULATION 63
4.6.1.2 RISK CLASSIFICATION 63
4.6.1.3 REGISTRATION PATHWAYS 64
4.6.2 INDIA 64
4.6.2.1 REGULATION 64
4.6.2.2 RISK CLASSIFICATION 64
4.6.2.3 REGISTRATION PATHWAYS 65
4.6.3 JAPAN 65
4.6.3.1 REGULATION 65
4.6.3.2 RISK CLASSIFICATION 65
4.6.3.3 REGISTRATION PATHWAYS 66
4.6.4 SINGAPORE 66
4.6.4.1 REGULATION 66
4.6.4.2 RISK CLASSIFICATION 67
4.6.4.3 REGISTRATION PATHWAYS 67
4.6.5 SOUTH KOREA 67
4.6.5.1 REGULATION 67
4.6.5.2 RISK CLASSIFICATION 67
4.6.5.3 REGISTRATION PATHWAYS 68
5 EPIDEMIOLOGY 69
5.1 OVERVIEW 69
5.2 PREVALENCE OF SENSORINEURAL HEARING LOSS, BY AGE GROUP 70
5.3 PREVALENCE OF CONDUCTIVE HEARING LOSS, BY AGE GROUP 71
6 REGIONAL SUMMARY 72
7 MARKET OVERVIEW 73
7.1 DRIVERS 75
7.1.1 INCREASING PREVALENCE OF HEARING LOSS CASES 75
7.1.2 INCREASING AWARENESS REGARDING THE BENEFITS OF EARLY DIAGNOSIS 76
7.1.3 GOVERNMENT INITIATIVE FOR HEARING LOSS AWARENESS 77
7.1.4 TECHNOLOGICAL ADVANCEMENT IN THE FIELD OF HEALTHCARE TECHNOLOGY 78
7.2 RESTRAINTS 78
7.2.1 HIGH COST ATTACHED WITH THE PRODUCT MANUFACTURING AND R&D 78
7.2.2 SUSCEPTIBLE TO WAX BUILD-UP 79
7.3 OPPORTUNITIES 80
7.3.1 RISING COLLABORATION, MERGER, & ACQUISITION AMONG THE MARKET PLAYERS 80
7.3.2 INCREASING INVESTMENTS IN HEALTHCARE SEGMENTS 80
7.3.3 BENEFITS ASSOCIATED WITH HEARING AIDS 81
7.3.4 RISING NUMBER OF COMPANIES ENTERING MARKET 81
7.4 CHALLENGES 82
7.4.1 DISRUPTION IN SUPPLY CHAIN INDUSTRY 82
7.4.2 VERY SLOW SOFTWARE UPGRADATION 83
8 ASIA-PACIFIC HEARING AID MARKET, BY PRODUCT TYPE 84
8.1 OVERVIEW 85
8.2 HEARING AID DEVICE 86
8.2.1 RECEIVER-IN-EAR HEARING AIDS (RIC) 87
8.2.1.1 RECHARGEABLE 88
8.2.1.2 NON-RECHARGEABLE 88
8.2.2 BEHIND-THE-EAR HEARING AIDS (BTE) 88
8.2.2.1 STANDARD BEHIND-THE EAR HEARING 88
8.2.2.1.1 RECHARGEABLE 88
8.2.2.1.2 NON-RECHARGEABLE 89
8.2.2.2 POWER PLUS BEHIND-THE EAR HEARING 89
8.2.2.2.1 RECHARGEABLE 89
8.2.2.2.2 NON-RECHARGEABLE 89
8.2.3 IN-THE-EAR-HEARING AIDS (ITE) 89
8.2.3.1 RECHARGEABLE 90
8.2.3.2 NON-RECHARGEABLE 90
8.2.4 IN-THE-CANAL (ITC) HEARING AIDS 90
8.2.5 COMPLETELY-IN-CANAL (CIC) HEARING AIDS 90
8.2.6 INVISIBLE-IN-CANAL (IIC) HEARING AIDS 90
8.3 HEARING IMPLANTS 90
8.3.1 COCHLEAR IMPLANTS 91
8.3.2 BONE CONDUCTION DEVICES 91
8.3.3 MIDDLE EAR IMPLANTS 91
8.3.4 AUDITORY BRAIN STEM IMPLANTS 92
8.4 HEARING AID ACCESSORIES 92
8.4.1 HEARING AID BATTERIES 93
8.4.2 WIRELESS ACCESSORIES 93
8.4.2.1 MICROPHONE 94
8.4.2.2 RECEIVER 94
8.4.2.3 REMOTE 94
8.4.3 HEARING PROTECTION 94
8.4.4 WAX GUARD FILTERS 94
8.4.5 OTHERS 94
9 ASIA-PACIFIC HEARING AID MARKET, BY HEARING LOSS 95
9.1 OVERVIEW 96
9.2 SENSORINEURAL LOSS 97
9.2.1 HEARING AID DEVICE 97
9.2.2 HEARING & IMPLANTS 97
9.2.3 HEARING AID ACCESSORIES 98
9.3 CONDUCTIVE LOSS 98
9.3.1 HEARING AID DEVICE 98
9.3.2 HEARING & IMPLANTS 98
9.3.3 HEARING AID ACCESSORIES 98
9.4 MIXED HEARING LOSS 99
9.4.1 HEARING AID DEVICE 99
9.4.2 HEARING & IMPLANTS 99
9.4.3 HEARING AID ACCESSORIES 99
9.5 AUDITORY NEUROPATHY SPECTRUM DISORDER (ANSD) 100
9.5.1 HEARING AID DEVICE 100
9.5.2 HEARING & IMPLANTS 100
9.5.3 HEARING AID ACCESSORIES 100
10 ASIA-PACIFIC HEARING AID MARKET, BY PATIENT TYPE 101
10.1 OVERVIEW 102
10.2 GERIATRIC 103
10.3 ADULTS 103
10.4 PEDIATRICS 104
11 ASIA-PACIFIC HEARING AID MARKET, BY TECHNOLOGY 105
11.1 OVERVIEW 106
11.2 DIGITAL SIGNAL PROCESSING 107
11.3 WIRELESS HEARING AID 108
11.3.1 BLUETOOTH COMPATIBILITY 108
11.3.2 FM COMPATIBILITY 108
11.4 DIRECTIONAL MICROPHONE SYSTEMS 109
11.5 ARTIFICIAL INTELLIGENCE 109
11.6 DIGITAL NOISE REDUCTION 109
11.6.1 IMPULSE NOISE REDUCTION 110
11.6.2 WIND NOISE REDUCTION 110
11.7 FEEDBACK MANAGEMENT SYSTEMS 110
11.8 DATA LOGGING 110
11.9 TELECOIL 111
11.10 TINNITUS MASKING 111
11.11 OTHERS 111
12 ASIA-PACIFIC HEARING AID MARKET, BY END-USERS 112
12.1 OVERVIEW 113
12.2 HOSPITALS 114
12.3 SPECIALTY CLINICS 114
12.4 HOME CARE SETTINGS 115
12.5 OTHERS 115
13 ASIA-PACIFIC HEARING AID MARKET, BY DISTRIBUTION CHANNEL 116
13.1 OVERVIEW 117
13.2 DIRECT TENDER 118
13.3 RETAIL PHARMACY 118
13.4 HOSPITAL PHARMACY 119
13.5 ONLINE SALES 119
13.6 OTHERS 119
14 ASIA-PACIFIC HEARING AID MARKET, BY COUNTRY 120
14.1 CHINA 132
14.2 JAPAN 140
14.3 INDIA 148
14.4 AUSTRALIA 156
14.5 SOUTH KOREA 164
14.6 INDONESIA 172
14.7 THAILAND 180
14.8 SINGAPORE 188
14.9 PHILIPPINES 196
14.10 MALAYSIA 204
14.11 VIETNAM 212
14.12 TAIWAN 220
14.13 REST OF ASIA-PACIFIC 228
15 ASIA-PACIFIC HEARING AID MARKET: COMPANY LANDSCAPE 229
15.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 229
15.1.1 COMPANY SHARE ANALYSIS: CHINA 230
15.1.2 COMPANY SHARE ANALYSIS: JAPAN 231
15.1.3 COMPANY SHARE ANALYSIS: INDIA 232
15.1.4 COMPANY SHARE ANALYSIS: AUSTRALIA 233
15.1.5 COMPANY SHARE ANALYSIS: SOUTH KOREA 234
15.1.6 COMPANY SHARE ANALYSIS: INDONESIA 235
15.1.7 COMPANY SHARE ANALYSIS: THAILAND 236
15.1.8 COMPANY SHARE ANALYSIS: SINGAPORE 237
15.1.9 COMPANY SHARE ANALYSIS: PHILIPPINES 238
15.1.10 COMPANY SHARE ANALYSIS: MALAYSIA 239
15.1.11 COMPANY SHARE ANALYSIS: VIETNAM 240
15.1.12 COMPANY SHARE ANALYSIS: TAIWAN 241
16 SWOT ANALYSIS 242
17 COMPANY PROFILES 243
17.1 SONOVA 243
17.1.1 COMPANY SNAPSHOT 243
17.1.2 REVENUE ANALYSIS 243
17.1.3 SOLUTION PORTFOLIO 244
17.1.4 RECENT DEVELOPMENTS 244
17.2 WS AUDIOLOGY A/S 245
17.2.1 COMPANY SNAPSHOT 245
17.2.2 PRODUCT PORTFOLIO 245
17.2.3 RECENT DEVELOPMENTS 247
17.3 DEMANT A/S 248
17.3.1 COMPANY SNAPSHOT 248
17.3.2 REVENUE ANALYSIS 248
17.3.3 SOLUTION PORTFOLIO 249
17.3.4 RECENT DEVELOPMENTS 250
17.4 COCHLEAR LTD. 251
17.4.1 COMPANY SNAPSHOT 251
17.4.2 PRODUCT PORTFOLIO 251
17.4.3 RECENT DEVELOPMENTS 251
17.5 AMPLIFON 252
17.5.1 COMPANY SNAPSHOT 252
17.5.2 REVENUE ANALYSIS 252
17.5.3 SOLUTION PORTFOLIO 253
17.5.4 RECENT DEVELOPMENTS 253
17.6 ALPS 254
17.6.1 COMPANY SNAPSHOT 254
17.6.2 PRODUCT PORTFOLIO 254
17.6.3 RECENT DEVELOPMENTS 255
17.7 ARPHI 256
17.7.1 COMPANY SNAPSHOT 256
17.7.2 PRODUCT PORTFOLIO 256
17.7.3 RECENT DEVELOPMENTS 256
17.8 AUSTAR HEARING SCIENCE AND TECHNOLOGY (XIAMEN) CO., LTD. 257
17.8.1 COMPANY SNAPSHOT 257
17.8.2 PRODUCT PORTFOLIO 257
17.8.3 RECENT DEVELOPMENTS 258
17.9 BELTONE GROUP 259
17.9.1 COMPANY SNAPSHOT 259
17.9.2 PRODUCT PORTFOLIO 259
17.9.3 RECENT DEVELOPMENTS 259
17.10 BERNAFON 260
17.10.1 COMPANY SNAPSHOT 260
17.10.2 PRODUCT PORTFOLIO 260
17.10.3 RECENT DEVELOPMENTS 261
17.11 BOSTON SCIENTIFIC CORPORATION 262
17.11.1 COMPANY SNAPSHOT 262
17.11.2 REVENUE ANALYSIS 262
17.11.3 PRODUCT PORTFOLIO 263
17.11.4 RECENT DEVELOPMENTS 263
17.12 EARGO INC. 264
17.12.1 COMPANY SNAPSHOT 264
17.12.2 REVENUE ANALYSIS 264
17.12.3 PRODUCT PORTFOLIO 265
17.12.4 RECENT DEVELOPMENTS 265
17.13 GN HEARING 266
17.13.1 COMPANY SNAPSHOT 266
17.13.2 PRODUCT PORTFOLIO 266
17.13.3 RECENT DEVELOPMENTS 267

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.